Patient- and Clinician-Reported Outcomes of Tirbanibulin 1% in the Treatment of Actinic Keratosis on the Face and Scalp (PROAK Study). (2023). SKIN The Journal of Cutaneous Medicine, 7(6), s262. https://doi.org/10.25251/skin.7.supp.262